Preventive Anti-CD2 Treatment does not Impair Parasite Control in a Murine Toxoplasmosis Model

Targeting human CD2 with the monoclonal antibody (mAb) CB.219 reduces intestinal inflammation in a colitis model where T cells carry human CD2. Here, we asked whether this mAb has adverse effects on infection control. Mice expressing human CD2 on T cells (huCD2tg) were orally infected with Toxoplasm...

Descripción completa

Detalles Bibliográficos
Autores principales: Erben, U., Pawlowski, N. N., Heimesaat, M. M., Loddenkemper, C., Doerfel, K., Spieckermann, S., Siegmund, B., Kühl, A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Akadémiai Kiadó 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681358/
https://www.ncbi.nlm.nih.gov/pubmed/26716019
http://dx.doi.org/10.1556/1886.2015.00040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681358/
https://www.ncbi.nlm.nih.gov/pubmed/26716019
http://dx.doi.org/10.1556/1886.2015.00040

Ejemplares similares